WOCKPHARMA.BOWOCKPHARMA.BOBSE
Loading
R&D Expenses Over TimeContracting
Percentile Rank14
3Y CAGR-5.9%
5Y CAGR-10.6%
Year-over-Year Change
Research and development spending
3Y CAGR
-5.9%/yr
vs -16.0%/yr prior
5Y CAGR
-10.6%/yr
Recent acceleration
Acceleration
+10.1pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
6 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.19B | -9.8% |
| 2024 | $1.32B | -6.4% |
| 2023 | $1.41B | -1.4% |
| 2022 | $1.43B | -16.9% |
| 2021 | $1.72B | -17.3% |
| 2020 | $2.08B | -28.5% |
| 2019 | $2.91B | +1.3% |
| 2018 | $2.87B | -27.7% |
| 2017 | $3.97B | -20.2% |
| 2016 | $4.98B | - |